C-aryl glucoside SGLT2 inhibitors and method
US6936590B2 · kind B2 · utility
88Cited by
3References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 2002 |
| Grant date | Aug 30, 2005 |
| Priority date | — |
| Expiry date | Oct 5, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/7052
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method is provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of a compound of the formula alone or in combination with one or more other antidiabetic agent(s) or other therapeutic agent(s).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.